|
|
|
|
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
HOW CAN WE REVITALISE THE ANTIBIOTIC PIPELINE? Mark Jones, Head of Development, Basilea Pharmaceutica discussed how we can revitalise the antibiotic pipeline, in an interview with Amalie Holmgaard Mersh from Euractiv.  TOWARDS A RARE DISEASE MOONSHOT: SCALING UP PUBLIC PRIVATE PARTNERSHIPS TO ACCELERATE RESEARCH A new initiative was launched at the European Health Summit. The ‘Rare Disease Moonshot’ is a commitment and collaboration between seven organisations to boost research into rare diseases through public-private partnerships. It targets the world’s rarest and severe conditions which currently have no therapeutic options, and which often affect the youngest patients. 
|
|
|
|
|||
|
||||
|
EFPIA 2026 All rights reserved ·
Disclaimer
·
|